Yusuf Erkul

Co-founder, CEO at Kernal Bio

Co-founder

Kernal Biologics· Summer 2020 🇺🇸 Cambridge, Massachusetts, United States

in LinkedIn 𝕏 @yusuf_erkul

2016Co-founder· Kernal Biologics, Inc.

Founder · since 2016

Company

Kernal Biologics, Inc.

Role

Co-founder, CEO

current

Stage

—

no public source

Raised

—

no public source

Based

Cambridge, Massachusetts

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Kernal Biologics

Kernal is creating mRNA 2.0 therapies that work in specific cells

Summer 2020

Experience

Career

Kernal Biologics, Inc.
Co-founder
Co-founder, CEO · Cambridge, Massachusetts · 2016 – Present
2016
Sentegen Biotech
Director · 2014 – 2016
2014
Merck
Research Biologist · Boston · 2009 – 2011
2009
Merck
Research Associate · Greater Boston · 2008 – 2009
2008
Merck
Summer Intern · Greater Boston · 2008
2008
MIT
Undergraduate Research Student · Greater Boston · 2008
2008
Harvard Medical School / Beth Israel Deaconess Medical Center
Undergraduate Research Student · Greater Boston Area · 2007 – 2008
2007

Bio

I'm co-founder and CEO of Kernal Biologics, a Boston-based biotech startup developing next-generation messenger RNA immunotherapy. Backed by Hummingbird, Amgen, Lilly, NVIDIA, HBM, NASA, and Boeing, Kernal Bio raised more than $30M. Early in my career, I worked at Merck&Co. on the discovery and development of various oncology drugs, including ZEJULA®, which got FDA approval for ovarian cancer. I hold an executive MBA from MIT Sloan, an M.D. from Hacettepe Univ. and a B.S. in Biology from MIT.